Tech Company Financing Transactions

BioNumerik Pharmaceuticals Funding Round

BioNumerik Pharmaceuticals secured a $9.5 million investment round on 12/31/2012. Investors included private investors.

Transaction Overview

Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$9,491,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8122 Datapoint Dr. 1250
San Antonio, TX 78229
USA
Email Address
Overview
BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.
Profile
BioNumerik Pharmaceuticals LinkedIn Company Profile
Social Media
BioNumerik Pharmaceuticals Company Twitter Account
Company News
BioNumerik Pharmaceuticals News
Facebook
BioNumerik Pharmaceuticals on Facebook
YouTube
BioNumerik Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Steve Carchedi
  Steve Carchedi LinkedIn Profile  Steve Carchedi Twitter Account  Steve Carchedi News  Steve Carchedi on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2012: Relay Network venture capital transaction
Next: 12/31/2012: Cryothermic Systems venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary